AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Bacterial Infections: Apramycin is effective against a wide range of bacterial infections in animals, including those caused by Gram-negative bacteria. It's commonly used to treat respiratory infections, gastrointestinal infections, and urinary tract infections.
Respiratory Infections: Apramycin can be used to treat respiratory infections in animals, including pneumonia and bronchitis caused by susceptible bacteria.
Gastrointestinal Infections: Bacterial gastrointestinal infections, such as enteritis, colitis, and other digestive tract infections, can be treated with apramycin.
Urinary Tract Infections (UTIs): Apramycin may be used to treat urinary tract infections in animals caused by susceptible bacteria.
Prevention of Infections: In addition to treatment, apramycin is sometimes used prophylactically to prevent bacterial infections in livestock, particularly in situations where there's a high risk of infection.
Livestock Health: Apramycin can help improve overall livestock health by controlling bacterial infections, which can lead to increased productivity and reduced economic losses in animal farming.
(apralan, apravet, apramicina, apramycin, aprapharm, concentrat vo 57 apramycine)
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Pseudomonas sp. cn4902 | Increases |
species group | Pseudomonas putida group | Increases |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
2 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Pseudomonadaceae | family | Increases |
1 | 0 | Salmonella | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
1 | 0 | Pseudomonas | genus | Increases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.6 | 0.9 | -0.5 |
ADHD | 4.2 | 0.6 | 6 |
Age-Related Macular Degeneration and Glaucoma | 1.1 | 0.4 | 1.75 |
Allergic Rhinitis (Hay Fever) | 4 | 3 | 0.33 |
Allergies | 6.9 | 3.4 | 1.03 |
Allergy to milk products | 2.4 | 1.6 | 0.5 |
Alopecia (Hair Loss) | 1 | 0.6 | 0.67 |
Alzheimer's disease | 5 | 7.4 | -0.48 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 3.6 | 1.4 | 1.57 |
Ankylosing spondylitis | 4.9 | 1.5 | 2.27 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. β Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA β Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. β Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. β Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]